Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 4, pp. 335-346
Open Access | Times Cited: 24

Showing 24 citing articles:

Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach
Valeria Calcaterra, Sara Zanelli, Andrea Foppiani, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 95-95
Open Access | Times Cited: 7
Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
Shijie Qin, Yanhua Li, Likui Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 17
N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
Stefania Bellone, Eric R. Siegel, Alessandro D. Santin
Gynecologic Oncology Reports (2025), pp. 101682-101682
Open Access
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Emanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 273-273
Open Access
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review
Abby E. Rudolph, Nadine Al Akoury, Natalija Bogdanenko, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
María Stefania Infante, David Nemirovsky, Sean M. Devlin, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 116.e1-116.e12
Open Access | Times Cited: 12
Long COVID across SARS-CoV-2 variants, lineages, and sublineages
Sergio Padilla, Christian Ledesma, Javier García-Abellán, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109536-109536
Open Access | Times Cited: 4
Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
Stefania Bellone, Eric R. Siegel, David Scheim, et al.
Gynecologic Oncology Reports (2024) Vol. 51, pp. 101324-101324
Open Access | Times Cited: 3
Challenges and opportunities in long COVID research
Rebecca E. Hamlin, Catherine A. Blish
Immunity (2024) Vol. 57, Iss. 6, pp. 1195-1214
Closed Access | Times Cited: 3
Long-term effects of the COVID-19 pandemic for patients with cancer
Yana Debie, Ziyad Palte, H Salman, et al.
Quality of Life Research (2024) Vol. 33, Iss. 10, pp. 2845-2853
Open Access | Times Cited: 3
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes
Emmanuelle Gras, Tommaso Francesco Aiello, Mariana Chumbita, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 9, pp. 2364-2368
Closed Access | Times Cited: 2
The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms
Amanda M. Buck, Amelia N. Deitchman, Saki Takahashi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 6
Impact of Omicron variant infection on the liver, kidney, and coagulation system in patients undergoing elective surgery: a retrospective case-control study
Xiaojuan Xiong, Rui Li, Haoyu Pei, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 742-754
Open Access | Times Cited: 1
Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection
Yu Lei, Nansong Xu, Chuanying Niu, et al.
Virology (2024) Vol. 597, pp. 110142-110142
Closed Access | Times Cited: 1
Characterization of natural compounds derived from diatom C. gracilis as potential therapeutic agents: An in-silico networking and docking study
Raya Bhattacharjya, Hina Bansal, Seneha Santoshi, et al.
Algal Research (2024), pp. 103712-103712
Closed Access | Times Cited: 1
Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System Cancers and Their Correlation with COVID-19
Zuming Xiong, Yang Yong-jun, Wenxin Li, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 7, pp. 5515-5533
Open Access | Times Cited: 3
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations
Filippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1709-1709
Open Access | Times Cited: 3
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)
Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4777-4777
Open Access | Times Cited: 2
The Outcomes of Patients with Omicron Variant Infection who Undergo Elective Surgery: A Propensity-score-matched Case-control Study
Xiaojuan Xiong, Rui Li, Hong Yan, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 5, pp. 817-825
Open Access
Infectious diseases prophylaxis and treatment in cancer patients, with particular emphasis on COVID-19. Interdisciplinary Polish experts' position statement
Piotr Rutkowski, Bożena Cybulska-Stopa, Jacek Jassem, et al.
Nowotwory Journal of Oncology (2024)
Open Access
BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells
Ni Wang, Qing Lin, Huimin Fan, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 11
Open Access
Retrospective Analysis of the Characteristics of the Post-COVID Period in Patients with Type 2 Diabetes, Infected During Different Variant-Associated Periods of COVID-19
Saule Altynbekova, В. В. Фадеев, Z. Abilayuly, et al.
Diabetes Mellitus (2024) Vol. 27, Iss. 5, pp. 441-450
Open Access
Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2
Ferron F. Ocampo, Pathariya Promsena, Phillip Chan
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 6, pp. 345-356
Closed Access | Times Cited: 1
Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVID
Stefania Bellone, Eric R. Siegel, Alessandro D. Santin
Gynecologic Oncology Reports (2023) Vol. 50, pp. 101301-101301
Open Access
Page 1

Scroll to top